Month: December 2022
Prostate Cancer: Addition of short-term hormonal therapy to salvage Prostate bed radiation and pelvic lymph node radiation improves outcomes (SPPORT Trial)
The findings published in Lancet in SPPORT trial, an international, multicentre, randomised phase 3 trial. The patients after prostatectomy for prostate cancer who had a…
FDA approves Mosunetuzumab for relapsed or refractory Follicular Lymphoma
The FDA in December 2022 has approved Mosunetuzumab in relapsed or refractory Follicular Lymphoma. The drug is approved for patients who had received at least…